Generic Name: Vitrakvi ()
Vitrakvi Reviews
For Solid Tumors "I've only been taking Vitrakvi a couple months, for squamous cell cancer in left head and neck after already having chemo and radiation , with no fresh scans I can't say anything about effectiveness but I'm not expecting much of a turn around if at all , mainly because of negative prognosis. But I can say I haven't had any bad side effects , but I didn't with chemo either, lucky I guess. No nausea or anything like that so I would say don't concern over that . Good luck. Thank you Bayer very much for the opportunity ."
More about Vitrakvi (larotrectinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Imprints, shape & color data
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Patient resources
- Vitrakvi drug information
Professional resources
- Vitrakvi prescribing information
- Larotrectinib (AHFS Monograph)
Related treatment guides
- Solid Tumors
